Host cell protein characterisation during the downstream processing of monoclonal antibodies from mammalian cells
The biopharmaceutical industry is at a pivotal moment of its short history, with ‘blockbuster’ monoclonal antibody (mAb) biosimilars emerging and the ‘next generation’ of molecules beginning to make their mark. Concomitantly, regulatory constraints on manufacturers have amplified, with processes now...
Main Author: | Tarrant, R. D. R. |
---|---|
Published: |
University College London (University of London)
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626660 |
Similar Items
-
Characterisation of the bioreactor environment and its effect on mammalian cell performance in suspension culture during antibody production
by: Velez Suberbie, L.
Published: (2013) -
Optimisation of chromatography for downstream protein processing
by: Polykarpou, E.
Published: (2011) -
Design and characterisation of a parallel miniaturised bioreactor system for mammalian cell culture
by: Al-Ramadhani, O.
Published: (2015) -
Engineering characterisation of single-use bioreactor technology for mammalian cell culture applications
by: Odeleye, A. O. O.
Published: (2015) -
Evaluating the potential of continuous processes for monoclonal antibodies : economic, environmental and operational feasibility
by: Pollock, J. E.
Published: (2014)